My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
QC LABS, DBA CANNALYSIS, A CORPORATION
Clerk
>
Contracts / Agreements
>
Q
>
QC LABS, DBA CANNALYSIS, A CORPORATION
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/18/2018 2:31:00 PM
Creation date
12/18/2018 2:19:17 PM
Metadata
Fields
Template:
Contracts
Company Name
QC LABS, DBA CANNALYSIS, A CORPORATION
Contract #
A-2018-278
Agency
PLANNING & BUILDING
Council Approval Date
3/20/2018
Expiration Date
12/31/2020
Destruction Year
2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
30
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Letter from the CEO and Co -Founder of Cannalysis <br />Since our founding we have strived towards innovative, technology-based solutions for <br />large-scale cannabis testing. We employ a STEM (Science, Technology, Engineering, <br />and Math) based, professional workforce with deep expertise within the fields of <br />chemistry, biotechnology, robotics engineering, software development, laboratory <br />operations, and finance. Our team combines their intelligence and expertise with the <br />latest laboratory and information technologies to position Cannalysis at the bar -setting <br />forefront of quality control and regulatory compliance in the testing of medicinal and <br />recreational cannabis products <br />We committed to investing in state-of-the-art lab equipment in our Santa Ana <br />Headquarters to ensure we were among the first cannabis testing labs to receive the <br />rigorous ISO/IEC 17025:2005 Accreditation in California. Additionally, Cannalysis is the <br />largest licensed cannabis testing facility in the country. Consequently, our team is well <br />positioned to continue establishing the gold standard for quality and delivery of <br />innovative testing services while setting the bar for added value to our clients. <br />We deliver increased transparency of cannabis products to inform both supply chain and <br />consumer decision-making and reduce environmental impact. Our testing services provide <br />information on acceptable amounts of compounds to verify products are safe for human <br />consumption and to inform consumers about product potency parameters. To help ensure <br />our clients and consumers are protected, the senior executives and scientists of <br />Cannalysis meet regularly with policy makers and state legislators to ensure consumers <br />are protected by the same regulations as big pharma. Good governance is required to <br />continue increasing transparency for consumers. <br />We are working to ensure Canalysis delivers information to further inform consumers, <br />thereby helping to promote informed, responsible use of cannabis products. Cannalysis is <br />innovating new ways of thinking about and operating within the cannabis market. <br />We have ambitious goals and we are working everyday with our talented team of <br />professionals, stakeholders and community to continue to improve the value Cannalysis <br />creates and delivers as the demand for testing increases. <br />With many lessons learned to date, 2018 is marking another successful year in our pursuit <br />of increasing transparency throughout the cannabis supply chain. <br />Brian Lannon <br />CEO and Co -Founder of Cannalysis <br />2lpage <br />
The URL can be used to link to this page
Your browser does not support the video tag.